50% of patients PRINCETON, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused ...

The NCI will lead the trial of the firm's Versamune MUC1 immunotherapy and its antibody-drug conjugate PDS01ADC.

Agartala: A team of officials from Assam govt visited Tripura recently and studied the Public Distribution System (PDS) as ...

Nath Bio-Genes (India) Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 271.68 Crore) operating in Agriculture/Horticulture ...